Separation induced changes in squirrel monkey hypothalamic-pituitary- adrenal physiology resemble aspects of hypercortisolism in humans

Psychoneuroendocrinology

Volumn 24, Issue 2, 1999, Pages 131-142

  Lyons, David M ^a   Wang, Oliver J ^a   Lindley, Steven E ^a   Levine, Seymour ^b   Kalin, Ned H ^c   Schatzberg, Alan F ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Catecholamine metabolites; Corficotropin releasing factor; Corticosteroid feedback; Depression; Metyrapone; Stress

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HOMOVANILLIC ACID; HYDROCORTISONE; METYRAPONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; FEEDBACK SYSTEM; HUMAN; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; SOCIAL ISOLATION; SQUIRREL MONKEY;

ADRENAL GLANDS; ADRENOCORTICAL HYPERFUNCTION; ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANXIETY, SEPARATION; CORTICOTROPIN-RELEASING HORMONE; FEEDBACK; FEMALE; HOMOVANILLIC ACID; HUMANS; HYDROCORTISONE; HYPOTHALAMUS; MALE; METYRAPONE; PITUITARY GLAND; SAIMIRI;

EID: 0032981315     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(98)00065-1     Document Type: Article

References (41)

1. Aberg-Wistedt A., Wistedt B., Bertilsson L. Higher CSF levels of HVA and 5-HIAA in delusional compared to nondelusional depression. Archives of General Psychiatry. 42:1985;925-926.
2. Amsterdam J. D., Maislin G., Berwish N., Phillips J., Winokur A. Enhanced adrenocortical sensitivity to submaximal doses of cosyntropin (α1-24 corticotropin) in depressed patients. Archives of General Psychiatry. 46:1989;550-554.
3. Blichert-Toft M., Hummer L. Serum immunoreactive corticotrophin and response to metyrapone in old age in man. Gerontology. 23:1977;236-243.
4. Breier A., Kelsoe J. R., Kirwin P. D., Beller S. A., Wolkowitz O. M., Pickar D. Early parental loss and development of adult psychopathology. Archives of General Psychiatry. 45:1988;987-993.
5. Chang W- H., Scheinin M., Burns R. S., Linnoila M. Rapid and simple determination of homovanillic acid in plasma using high performance liquid chromatography with electrochemical detection. Acta Pharmacologica et Toxicologica. 53:1983;275-279.
6. De Souza E., Van Loon G. R. Corticotrophin releasing factor increases the adrenocortical responsiveness to adrenocorticotropin. Experientia. 40:1984;1004-1006.
7. Devanand D. P., Bowers M. B., Hoffman F. J., Nelson J. C. Elevated plasma homovanillic acid in depressed females with melancholia and psychosis. Psychiatry Research. 15:1985;1-4.
8. Garrick N. A., Hill J. L., Szele F. G., Tomai T. P., Gold P. W., Murphy D. L. Corticotropin-releasing factor: A marked circadian rhythm in primate cerebrospinal fluid peaks in the evening and is inversely related to the cortisol circadian rhythm. Endocrinology. 121:1987;1329-1334.
9. Gold P. W., Loriaux D. L., Roy A., Kling M. A., Calabrese J. R., Kellner C. H., Nieman L. K., Post R. M., Pickar D., Gallucci W., Averginos P., Paul S., Oldfield E. H., Cutler G. B., Chrousos G. P. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. New England Journal of Medicine. 314:1986;1329-1335.
10. Jasper M. S., Engeland W. C. Splanchnic neural activity modulates ultradian and circadian rhythms in adrenocortical secretion in awake rats. Neuroendocrinology. 59:1994;97-109.
11. Jubiz W., Matsukura S., Meikle A. W., Harada G., West C. D., Tyler F. J. Plasma metyrapone, adrenocorticotropic hormone, cortisol, and deoxycortisol levels. Archives of Internal Medicine. 125:1970;468-471.
12. Kalin N. H., Dawson G., Tariot P., Shelton S., Barksdale C., Weiler S., Thienemann M. Function of the adrenal cortex in patients with major depression. Psychiatry Research. 22:1987;117-125.
13. Kalin N. H., Shelton S. E., Barksdale C. M., Brownfield M. S. A diurnal rhythm in cerebrospinal fluid corticotropin-releasing hormone different from the rhythm of pituitary-adrenal activity. Brain Research. 426:1987;385-391.
14. Kalin N. H., Shelton S. E., Turner J. G. Effects of Alprazolam on fear-related behavioral, hormonal, and catecholamine responses in infant rhesus monkeys. Life Sciences. 49:1991;2031-2044.
15. Kling M. A., Roy A., Doran A. R., Calabrese J. R., Rubinow D. R., Whitfield J. R., May C., Post R. M., Chrousos G. P., Gold P. W. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: Potential clinical implications. Journal of Clinical Endocrinology and Metabolism. 72:1991;260-271.
16. Kolanowski J., Pizzarro M. A., Crabbe J. Potentiation of adrenocortical response upon intermittent stimulation with corticotropin in normal subjects. Journal of Clinical Endocrinology and Metabolism. 41:1975;453-465.
17. Kopin I. J., Bankiewicz K. S., Harvey-White J. Assessment of brain dopamine metabolism from plasma HVA and MHPG during debrisoquin treatment: Validation in monkeys treated with MPTP. Neuropsychophamacology. 1:1988;119-125.
18. Lyons D. M., Levine S. Socioregulatory effects on squirrel monkey pituitary-adrenal activity: A longitudinal analysis of cortisol and ACTH. Psychoneuroendocrinology. 19:1994;283-291.
19. Lyons D. M., Ha C. M. G., Levine S. Social effects and circadian rhythms in squirrel monkey pituitary-adrenal activity. Hormones and Behavior. 29:1995;177-190.
20. Mazure C. M., Bowers M. B., Hoffman F., Miller K. B., Nelson J. C. Plasma catecholamine metabolites in subtypes of major depression. Biological Psychiatry. 22:1987;1469-1472.
21. Nelson J. C., Davis J. M. DST studies in psychotic depression: A meta-analysis. American Journal of Psychiatry. 154:1997;1497-1503.
22. Nemeroff C. B., Widerlov E., Bissette G., Walleus H., Karlsson I., Kilts C. D., Lossen P. T., Vale W. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science. 226:1984;1342-1344.
23. Ottenweller J. E., Meier A. H. Adrenal innervation may be an extrapituitary mechanism able to regulate adrenocortical rhythmicity in rats. Endocrinology. 111:1982;1134-1138.
24. Owens M. J., Nemeroff C. B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacological Reviews. 106:1991;425-473.
25. Pedersen R. C., Browne A. C. Adrenocortical response to corticotropin is potentiated by part of the amino-terminal region of pro-corticotropin/endorphin. Proceedings of the National Academy of Science USA. 77:1980;2239-2243.
26. Piazza P. V., Rouge-Pont F., Deroche V., Maccari S., Simon H., Le Moal M. Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission. Proceedings of the National Academy of Science USA. 93:1996;8716-8720.
27. Posener J. A., Schildkraut J. J., Williams G. H., Gleason R. E., Salomon M. S., Mecheri G., Schatzberg A. F. Acute and delayed effects of corticotropin-releasing hormone on dopamine activity in man. Biological Psychiatry. 36:1994;616-621.
28. Rivier C., Vale W. Diminished responsiveness of the hypothalamic-pituitary-adrenal axis of the rat during exposure to prolonged stress: A pituitary-mediated mechanism. Endocrinology. 121:1987;1320-1328.
29. Rothschild A. J., Langlais P. J., Schatzberg A. F., Walsh F. X., Cole J. O., Bird E. D. Dexamethasone increases plasma free dopamine in man. Journal of Psychiatric Research. 18:1984;217-233.
30. Rothschild A. J., Langlais P. J., Schatzberg A. F., Miller M. M., Saloman M. S., Lerbinger J. E., Cole J. O., Bird E. D. The effects of a single acute dose of dexamethasone on monoamine and metabolite levels in rat brain. Life Sciences. 36:1985;2491-2501.
31. Rothschild A. J., Schatzberg A. F., Langlais P. J., Lerbinger J. E., Miller M. M., Cole J. O. Psychotic and nonpsychotic depressions: I. Comparison of plasma catecholamines and cortisol measures. Psychiatry Research. 20:1987;143-153.
32. Shanker G., Sharma R. K. β-endorphin stimulates corticosterone synthesis in isolated rat adrenal cells. Biochemical and Biophysical Research Communications. 86:1979;1-5.
33. Sonino N., Fava G. A., Boscaro M. A role for life events in the pathogenesis of Cushing's disease. Clinical Endocrinology. 38:1993;261-264.
34. Thomas G. B. Calculus and Analytic Geometry. 1972;Addison-Wesley, Menlo Park, CA.
35. Ur E., Dinan T. G., O'Keane V., Clare A. W., McLoughlin L., Rees L. H., Turner T. H., Grossman A., Besser G. M. Effect of metyrapone on the pituitary-adrenal axis in depression: Relation to dexamethasone suppressor status. Neuroendocrinology. 56:1992;533-538.
36. von Bardeleben U., Stalla G. K., Muller O. A., Holsboer F. Blunting of ACTH response to human CRF in depressed patients is avoided by metryapone pretreatment. Biological Psychiatry. 24:1988;782-786.
37. Wiener S. G., Bayart F., Faull K. F., Levine S. Behavioral and physiological responses to maternal separation in squirrel monkeys (Saimiri sciureus). Behavioral Neuroscience. 104:1990;108-115.
38. Wolkowitz O., Sutton M., Koulu M., Labarca R., Wilkinson L., Doran A., Hauger R., Pickar D., Crawley J. Chronic corticosterone administration in rats: Behavioral and biochemical evidence of increase central dopaminergic activity. European Journal of Pharmacology. 122:1986;329-338.
39. Wolkowitz O. M., Doran A. R., Breier A., Roy A., Jimerson D. C., Sutton M. E., Golden R. N., Paul S. M., Pickar D. The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Archives of General Psychiatry. 44:1987;782-789.
40. Young E. A., Akil H. Corticotropin-releasing factor stimulation of adrenocorticotropin and beta-endorphine release: Effects of acute and chronic stress. Endocrinology. 117:1985;23-30.
41. Young E. A., Akil H., Haskett R. F., Watson S. J. Evidence against changes in corticotroph CRF receptors in depressed patients. Biological Psychiatry. 37:1995;355-363.